Clinical observation of the efficacy of intracavitary injection of endostar combined with chemotherapy on ma-lignant pleural effusion
10.3760/cma.j.issn.1008-6706.2015.08.032
- VernacularTitle:重组人血管内皮抑制素联合腔内化疗治疗恶性胸腔积液疗效观察
- Author:
Wenbing ZHANG
;
Tongfang XIE
- Publication Type:Journal Article
- Keywords:
Endostar;
Malignant pLeuraL effusion;
Intracavitary chemotherapy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(8):1212-1214
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and safety of intracavitary injection of endostar combined with chemotherapy of malignant pleural effusion.Methods 46 cases with malignant pleural effusion were divided into groups of intracavitary injection of endostar combined with chemotherapy of malignant pleural effusion (treatment group)and groups of intracavitary chemotherpy(control group)randomly,pleural effusion of the patients from the two groups were injected cisplatin(DDP)60mg into the thorax and 45mg of endostar,The same therapy applied to the control group except adding endostar,twice a week,in 2 -4 rounds,the efficacy and safety of the two groups were studied.Results The effective rate of the treatment groups was 58.3%,which was higher than 31.8%of the control group (χ2 =4.547,P<0.05).The improvement rate of quality of life was 75.0% in the treatment group,which was higher than 59.1% in the control group (χ2 =5.371,P<0.05).The toxicities of the treatment group were not increased significantly.Conclusion The therapy of intracavitary injection of endostar combined with chemotherapy of malignant pleural effusion is effective and secure.
